367
Views
10
CrossRef citations to date
0
Altmetric
Research Article

An Evidence-Based Systematic Review of Umckaloabo (Pelargonium sidoides) by the Natural Standard Research Collaboration

, PharmD, , PharmD, , PhD, , BA, BS, , PhD, , PhD, , , PharmD, , PharmD, , PharmD, , BA & , MPH show all
Pages 283-302 | Published online: 10 Aug 2010

REFERENCES

  • Beil W, Kilian P. EPs 7630, an extract from Pelargonium sidoides roots inhibits adherence of Helicobacter pylori to gastric epithelial cells. Phytomedicine. 2007; 14(Suppl 6): 5–8.
  • Bereznoy VV, Riley DS, Wassmer G, Heger M. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial. Altern Ther Health Med. 2003; 9(5): 68–79.
  • Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial. Explore (NY). 2005; 1(6): 437–445.
  • Conrad A, Hansmann C, Engels I, Daschner FD, Frank U. Extract of Pelargonium sidoides (EPs 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro. Phytomedicine. 2007a; 14(Suppl 6): 46–51.
  • Conrad A, Jung I, Tioua D, Lallemand C, Carrapatoso F, Engels I, Daschner FD, Frank U. Extract of Pelargonium sidoides (EPs 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro. Phytomedicine. 2007b; 14(Suppl 6): 52–59.
  • Conrad A, Kolodziej H, Schulz V. [Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety]. Wien Med Wochenschr. 2007c; 157(13–14): 331–336.
  • de Boer HJ, Hagemann U, Bate J, Meyboom RH. Allergic reactions to medicines derived from Pelargonium species. Drug Saf. 2007; 30(8): 677–680.
  • Fukuda H, Kishii R, Takei M, Hosaka M. Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae. Antimicrob Agents Chemother. 2001; 45(6): 1649–1653.
  • Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17(1): 1–12.
  • Kayser O, Kolodziej H. Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme. Planta Med. 1997; 63(6): 508–510.
  • Kayser O, Kolodziej H, Kiderlen AF. Immunomodulatory principles of Pelargonium sidoides. Phytother Res. 2001; 15(2): 122–126.
  • Koch E, Lanzendörfer-Goossens Wohn C. Stimulation of interferon (IFN)-â-synthesis and natural killer (NK) cell activity by an aqueous-ethanolic extract from roots of Pelargonium sidoides (Umckaloabo). Naunyn-Schmiederbergs Arch Pharmacol. 2002; 365(Suppl 1): R75.
  • Kolodziej H, Burmeister A, Trun W, Radtke OA, Kiderlen AF, Ito H, Hatano T, Yoshida T, Foo LY. Tannins and related compounds induce nitric oxide synthase and cytokines gene expressions in Leishmania major-infected macrophage-like RAW 264.7 cells. Bioorg Med Chem. 2005; 13(23): 6470–6476.
  • Kolodziej H, Kayser O, Radtke OA, Kiderlen AF, Koch E. Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine. 2003; 10(Suppl 4): 18–24.
  • Kolodziej H, Kiderlen AF. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs 7630. Phytomedicine. 2007; 14(Suppl 6): 18–26.
  • Lewu FB, Grierson DS, Afolayan AJ. Clonal propagation of Pelargonium sidoides: a threatened medicinal plant of South Africa. Afr J Biotechnol. 2006; 5: 123–125.
  • Lizogub VG, Riley DS, Heger M. Efficacy of a Pelargonium sidoides preparation in patients with the common cold: a randomized, double-blind, placebo-controlled clinical trial. Explore (NY). 2007; 3(6): 573–584.
  • Matthys H, Eisebitt R, Seith B, Heger M. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomized, double-blind, placebo-controlled trial. Phytomedicine. 2003; 10(Suppl 4): 7–17.
  • Matthys H, Heger M. EPs 7630-solution—an effective therapeutic option in acute and exacerbating bronchitis. Phytomedicine. 2007a; 14(Suppl 6): 65–68.
  • Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomized, double-blind, placebo-controlled, multicentre study. Curr Med Res Opin. 2007b; 23(2): 323–331.
  • Matthys H, Kamin W, Funk P, Heger M. Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children. Phytomedicine. 2007; 14(Suppl 6): 69–73.
  • Neugebauer P, Mickenhagen A, Siefer O, Walger M. A new approach to pharmacological effects on ciliary beat frequency in cell cultures—exemplary measurements under Pelargonium sidoides extract (EPs 7630). Phytomedicine. 2005; 12(1–2): 46–51.
  • Noldner M, Schotz K. Inhibition of lipopolysaccharid-induced sickness behavior by a dry extract from the roots of Pelargonium sidoides (EPs 7630) in mice. Phytomedicine. 2007; 14(Suppl 6): 27–31.
  • Schulz V. Liquid herbal drug preparation from the root of Pelargonium sidoides is effective against acute bronchitis: results of a double-blind study with 124 patients. Phytomedicine. 2007; 14(Suppl 6): 74–75.
  • Trun W, Kiderlen AF, Kolodziej H. Nitric oxide synthase and cytokines gene expression analyses in Leishmania-infected RAW 264.7 cells treated with an extract of Pelargonium sidoides (EPs 7630). Phytomedicine. 2006; 13(8): 570–575.
  • Wittschier N, Faller G, Hensel A. An extract of Pelargonium sidoides (EPs 7630) inhibits in situ adhesion of Helicobacter pylori to human stomach. Phytomedicine. 2007a; 14(4): 285–288.
  • Wittschier N, Lengsfeld C, Vorthems S, Stratmann U, Ernst JF, Verspohl EJ, Hensel A. Large molecules as anti-adhesive compounds against pathogens. J Pharm Pharmacol. 2007b; 59(6): 777–786.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.